Skip to main content
Fig. 2 | BMC Health Services Research

Fig. 2

From: Healthcare utilization and cost of cancer-related care prior to allogeneic hematopoietic cell transplantation for hematologic malignancies in the US: a retrospective real-world analysis

Fig. 2

Adjusted mean cancer-related healthcare costs for the overall observation period by type of hematologic malignancy. All commercially insured patients included. Adjusted for patient demographic and clinical characteristics. The percentages shown are approximated using data from different analyses. ALL, acute lymphocytic leukemia; AML, acute myelogenous leukemia; HCT, hematopoietic cell transplantation; MDS, myelodysplastic syndrome; MPD, myeloproliferative disorders; NHL, Non-Hodgkin’s lymphoma

Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us